UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

April 16 30, 2026

Date of report (Date of earliest event reported)

IMAX Corporation

(Exact Name of Registrant as Specified in Its Charter)

Canada

001-35066

98-0140269

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification Number)


2525 Speakman Drive			902 Broadway, Floor 20
Mississauga, Ontario, Canada L5K 1B1			New York, New York, USA 10010
(905) 403-6457			(212) 821-0142

(Address of principal executive offices, zip code, telephone numbers)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Shares, no par value

IMAX

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 52.02 Results ~~Departure~~ of ~~Directors~~Operations orand ~~Certain~~Financial ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~Condition

AsOn ~~previously announced on March~~ April 30, 2026, ~~Richard Gelfond, the Chief Executive Officer of~~ IMAX Corporation (the “Company”), isissued on a ~~temporary~~press ~~medical~~release ~~leave~~announcing ~~of absence. On April 16, 2026,~~ the Company’s ~~board~~financial ~~of directors (the “Board”) appointed Robert D. Lister, the Company’s Chief Legal Officer~~ and ~~Senior~~operating ~~Executive~~results ~~Vice~~for ~~President, to serve as~~ the ~~Company’s~~quarter ~~interim~~ended ~~principal~~March ~~executive officer (“PEO”) in addition to his current duties until May 1~~31, 2026, ~~following~~a ~~which~~copy ~~Mr. Gelfond will resume the role~~ of ~~PEO.~~which ~~Mr.~~is ~~Lister~~attached ~~will~~as ~~not~~Exhibit ~~receive any additional compensation in connection with his temporary interim appointment~~99. 1.

~~Biographical~~The ~~and other~~ information ~~for Mr. Lister are set forth~~ in ~~the~~this ~~Company’s~~current ~~definitive~~report ~~proxy statement~~ on ~~Schedule~~Form ~~14A~~8-K, ~~filed~~including ~~with~~ the ~~Securities~~Exhibit ~~and~~attached ~~Exchange~~hereto, ~~Commission~~is ~~(the~~being ~~“SEC”)~~furnished ~~on April 25, 2025~~ and ~~are~~shall ~~incorporated~~not ~~herein~~be bydeemed ~~reference.~~“filed” ~~Mr.~~for ~~Lister~~purposes isof ~~not~~Section a18 ~~party~~of tothe ~~any~~Securities ~~arrangement~~Exchange orAct ~~understanding~~of ~~pursuant~~1934, toas ~~which~~amended he(the ~~was~~“Exchange ~~appointed as interim PEO~~Act”), or tootherwise ~~any~~subject ~~transactions required~~ to bethe ~~disclosed~~liabilities ~~pursuant to Item 404(a)~~ of ~~Regulation~~that ~~S-K. The Company has not entered into~~section, ~~amended~~nor orshall ~~modified~~it ~~any~~be ~~plan,~~incorporated ~~contract,~~by ~~arrangement,~~reference ~~grant or award~~ in ~~connection~~any ~~with~~filing under the ~~interim~~Securities ~~appointment~~Act of ~~Mr.~~1933, ~~Lister.~~as ~~There~~amended, ~~are~~or nothe ~~family~~Exchange ~~relationships~~Act, ~~between~~except ~~Mr.~~as ~~Lister~~shall ~~and~~be ~~any~~expressly ofset ~~the~~forth ~~Company’s~~by ~~other~~specific ~~directors~~reference orin ~~executive~~such ~~officers~~filing.

Item 9.01 Financial Statements and Exhibits

Exhibits


Exhibit No.						Description

99.1						Press Release dated April 30 , 2026

104						Cover Page Interactive Data File (formatted as inline XBRL).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	IMAX Corporation
	(Registrant)
Date: April 17, 2026	By:	/s/ Natasha Fernandes
Date: April 30, 2026	By:	/s/ Robert D. Lister
	Name:	~~Natasha~~Robert ~~Fernandes~~D. Lister
	Title:	Chief ~~Financial~~Legal Officer and Senior Executive Vice President (Interim Principal Executive Officer)
	By:	/s/ Kenneth I. Weissman
	Name:	Kenneth I. Weissman
	Title:	Deputy General Counsel & Corporate Secretary

Filing Compare · IMAX CORP